Works matching IS 20457634 AND DT 2022 AND VI 11 AND IP 22


Results: 29
    1

    Race‐specific prostate cancer outcomes in a cohort of military health care beneficiaries undergoing surgery: 1990–2017.

    Published in:
    Cancer Medicine, 2022, v. 11, n. 22, p. 4354, doi. 10.1002/cam4.4787
    By:
    • Oehrlein, Nathan;
    • Streicher, Samantha A.;
    • Kuo, Huai‐Ching;
    • Chaurasia, Avinash;
    • McFadden, Jacob;
    • Nousome, Darryl;
    • Chen, Yongmei;
    • Stroup, Sean P.;
    • Musser, John;
    • Brand, Timothy;
    • Porter, Christopher;
    • Rosner, Inger L.;
    • Chesnut, Gregory T.;
    • Onofaro, Kayla C.;
    • Rebbeck, Timothy R.;
    • D'Amico, Anthony;
    • Lu‐Yao, Grace;
    • Cullen, Jennifer
    Publication type:
    Article
    2
    3
    4

    Germline mutations in penetrant cancer predisposition genes are rare in men with prostate cancer selecting active surveillance.

    Published in:
    Cancer Medicine, 2022, v. 11, n. 22, p. 4332, doi. 10.1002/cam4.4778
    By:
    • Brady, Lauren;
    • Newcomb, Lisa F.;
    • Zhu, Kehao;
    • Zheng, Yingye;
    • Boyer, Hilary;
    • Sarkar, Navonil De;
    • McKenney, Jesse K.;
    • Brooks, James D.;
    • Carroll, Peter R.;
    • Dash, Atreya;
    • Ellis, William J.;
    • Filson, Christopher P.;
    • Gleave, Martin E.;
    • Liss, Michael A.;
    • Martin, Frances;
    • Morgan, Todd M.;
    • Thompson, Ian M.;
    • Wagner, Andrew A.;
    • Pritchard, Colin C.;
    • Lin, Daniel W.
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25

    Treatment patterns, effectiveness, and patient‐reported outcomes of palbociclib therapy in Chinese patients with advanced breast cancer: A multicenter ambispective real‐world study.

    Published in:
    Cancer Medicine, 2022, v. 11, n. 22, p. 4157, doi. 10.1002/cam4.4767
    By:
    • Shen, Lesang;
    • Zhou, Jun;
    • Chen, Yiding;
    • Ding, Jinhua;
    • Wei, Haiyan;
    • Liu, Jian;
    • Xia, Wenjie;
    • Xie, Bojian;
    • Xie, Xiaohong;
    • Li, Xujun;
    • Dai, Yuechu;
    • Zhang, Guobing;
    • Qiu, Xia;
    • Li, Chao;
    • Sun, Shanshan;
    • Chen, Wuzhen;
    • Gong, Dihe;
    • Li, Hengyu;
    • Huang, Jian;
    • Jiang, Xia
    Publication type:
    Article
    26
    27

    Factors associated with adherence to colonoscopy among individuals who were positive in the preliminary screening for colorectal neoplasms.

    Published in:
    Cancer Medicine, 2022, v. 11, n. 22, p. 4321, doi. 10.1002/cam4.4730
    By:
    • Li, Ji‐Bin;
    • Ke, Keng‐Jian;
    • Zhang, Wei‐Li;
    • Wang, Ling‐Yan;
    • Wu, Yan‐Ping;
    • Weng, Fan;
    • Tian, Huan;
    • Qiu, Zhi‐Yu;
    • Li, Yin;
    • Lin, Shi‐Yong;
    • Ye, Mei‐Xian;
    • Ou, Qing‐Jian;
    • Gong, Cheng‐Hua;
    • Lu, Zhen‐Hai;
    • Pan, Zhi‐Zhong;
    • Wan, De‐Sen;
    • Peng, Jian‐Hong;
    • Fang, Yu‐Jing
    Publication type:
    Article
    28

    Performance status (PS) as a predictor of poor response to immune checkpoint inhibitors (ICI) in recurrent/metastatic head and neck cancer (RMHNSCC) patients.

    Published in:
    Cancer Medicine, 2022, v. 11, n. 22, p. 4104, doi. 10.1002/cam4.4722
    By:
    • Chalker, Cameron;
    • Voutsinas, Jenna M.;
    • Wu, Qian Vicky;
    • Santana‐Davila, Rafael;
    • Hwang, Victoria;
    • Baik, Christina S.;
    • Lee, Sylvia;
    • Barber, Brittany;
    • Futran, Neal D.;
    • Houlton, Jeffrey J.;
    • Laramore, George E.;
    • Liao, Jay Justin;
    • Parvathaneni, Upendra;
    • Martins, Renato G.;
    • Eaton, Keith D.;
    • Rodriguez, Cristina P.
    Publication type:
    Article
    29

    Issue Information.

    Published in:
    Cancer Medicine, 2022, v. 11, n. 22, p. 4079, doi. 10.1002/cam4.4009
    Publication type:
    Article